⚖️

Weight Loss Peptides

GLP-1 receptor agonists, lipolytic compounds, and metabolic peptides studied for body composition, appetite regulation, and fat oxidation.

Research Compounds

8 peptides in this category

GLP-1 Agonist FDA Approved

A GLP-1 receptor agonist studied extensively for weight management and glycaemic control. One of the most researched metabolic peptides.

GIP/GLP-1 FDA Approved

Dual GIP and GLP-1 receptor agonist showing superior weight reduction outcomes in clinical trials versus single-agonist compounds.

Lipolytic Research

A fragment of human growth hormone (hGH176-191) researched for fat metabolism and lipolysis without affecting IGF-1 levels.

GHRH Analogue Research

A growth hormone releasing hormone analogue that promotes pulsatile GH release, indirectly supporting fat metabolism and lean mass.

GHRP Research

A selective growth hormone secretagogue with minimal cortisol and prolactin release. Often stacked with CJC-1295 for body composition.

Mitochondrial Research

A mitochondria-derived peptide that regulates metabolic homeostasis and insulin sensitivity with promising research for obesity.

GHRH Analogue FDA Approved

A synthetic GHRH analogue FDA-approved for visceral fat reduction in HIV-associated lipodystrophy.

GLP-1 Agonist FDA Approved

A once-daily GLP-1 receptor agonist studied for weight management and cardiovascular risk reduction.

Tools and references for researching weight loss peptides

Calculate precise doses by body weight and vial concentration for any peptide in this category.

Design a complete research protocol with scheduling, cycling, and documentation for these compounds.

Review storage requirements, reconstitution guidance, and safety considerations for research peptides.

Other Categories